How much funding has Ribometrix raised?

Ribometrix has raised $45.3M in total funding, most recently a Venture Round.

Who are Ribometrix's investors?

Ribometrix's investors include M Ventures, Illumina Ventures, Dementia Discovery Fund, SV Health Investors, Amgen, Hatteras Venture Partners.

Where is Ribometrix headquartered?

Ribometrix is headquartered in Durham, North Carolina, United States.

What industry is Ribometrix in?

Ribometrix operates in Biotech, Drug Discovery.

How many employees does Ribometrix have?

Ribometrix has 11-50 employees.

Ribometrix

The Full Promise of RNA-Targeted Drugs

Durham, United States · $45.3M raised

Biotech

Drug Discovery

Headquarters: Durham, North Carolina
Employees: 11–50
Business Model: B2B
Website: ribometrix.com

Total Funding: $45.3M
Last Round: $7.8M Venture RoundSep 2019
Rounds: 3

About

Ribometrix is a drug-discovery company pioneering a new class of small-molecule therapeutics that directly target and modulate RNA biology to treat human diseases. The company has partnerships with Genentech (potential deal >$1B) and Vertex Pharmaceuticals, and raised $30M in 2018.

Summary

Ribometrix is a Biotech company based in Durham, United States. It has raised $45.3M in total across 3 rounds, most recently a $7.8M Venture Round round in Sep 2019. Investors include M Ventures, Illumina Ventures and Dementia Discovery Fund.